Literatur
-
1
Kraemer M, Heienbrok W, Berlit P.
Moyamoya Disease in Europeans.
Stroke.
2008;
39
3193-3200
-
2
Hoffman H J.
Moyamoya disease and syndrome.
Clin Neurol Neurosurg.
1997;
99 (Suppl 2)
39-44
-
3 Wakai K, Tamakoshi A, Ohno Y et al. Epidemiology of spontaneous occlusion of the circle of Willisi: results of national epidemiologic survey.The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare Japan: Annual Report 1995. Ministry of Health and Welfare Japan. Tokyo, Japan; 1995: 33-37
-
4
Achrol A S, Guzman R, Lee M et al.
Pathophysiology and genetic factors in moyamoya disease.
Neurosurg Focus.
2009;
26
pE4
-
5
Baba T, Houkin K, Kuroda S.
Novel epidemiological features of moyamoya disease.
J Neurol Neurosurg Psychiatry.
2008;
79
900-904
-
6
Chui D, Shedden P, Bratina P et al.
Clinical features of moyamoya isease in the United States.
Stroke.
1998;
29
1347-1351
-
7
Hallemeier C L, Rich K M, Grubb R L et al.
Clinical features and outcome in North American adults with moyamoya phenomenon.
Stroke.
2006;
37
1490-1496
-
8
Khan N, Schuknecht B, Boltshauser E et al.
Moyamoya disease and moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
Acta Neurochir.
2003;
145
1061-1071
-
9
Khan N, Yonekawa Y.
Moyamoya angiopathy in Europe.
Acta Neurochir Suppl.
2005;
94
149-152
-
10
Khan N, Yonekawa Y.
Moyamoya angiopathy in Europe: the beginnings in Zurich, practical lessons learned, increasing awareness and future perspectives.
Acta Neurochir Suppl.
2008;
103
127-30
-
11
Hanggi D, Mehrkens J H, Schmid-Elsaesser R et al.
Results of direct and indirect revascularisation for adult European patients with Moyamoya angiopathy.
Acta Neurochir Suppl.
2008;
103
119-22
-
12
Czabanka M, Vajkoczy P, Schmiedek P et al.
Age-dependent revascularization patterns in the treatment of moyamoya disease in a European patient population.
Neurosurg Focus.
2009;
26
E9
-
13
Vajkoczy P.
Moyamoya disease: collateralization is everything.
Cerebrovasc Dis.
2009;
28
258
-
14
Fukui M.
Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willisi (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.
Clin Neurol Neurosurg.
1997;
2
238-240
-
15
Rafat N, Beck G Ch, Pena-Tapia P G et al.
Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
Stroke.
2009;
40
432-438
-
16
Inoue T K, Ikezaki K, Sasazuki T et al.
DNA typing of HLA in the patients with moyamoya disease.
Jpn J Hum Genet.
1997;
42 (4)
507-515
-
17
Yamauchi T, Houkin K, Tada M et al.
Familial occurrence of moyamoya disease.
Clin Neurol Neurosurg.
1997;
99
162-167
-
18
Yamauchi T, Tada M, Houkin K et al.
Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willisi) to chromosome 17q25.
Stroke.
2000;
31
930-935
-
19
Kuroda S, Iwasaki Y.
Current review of familial moyamoya disease.
ippon Rinsho.
2006;
64
750-754
-
20
Inoue T K, Ikezaki K et al.
Linkage Analysis of Moyamoya Disease on Chromosome 6.
J Child Neurol..
2000;
15
179-182
-
21
Zafeiriou D I, Ikeda H, Anastasiou A et al.
Familial moyamoya disease in a Greek family.
Brain Dev.
2003;
25 (4)
288-290
-
22
Mineharu Y, Liu W, Inoue K et al.
Autosomal dominant moyamoya disease maps to chromosome 17q25.3.
Neurology 10.
2008;
70 (24 Pt 2)
2357-2363
-
23
Liu W, Hashikata H, Inoue K et al.
A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians.
Environ Health Prev Med.
2009;
19
1347-4715
-
24
Ikeda H, Sasaki T, Yoshimoto T et al.
Mapping of a familial moyamoya disease gene to chromosome 3 p24.2-p26.
Am J Hum Genet.
1999;
64 (2)
533-537
-
25
Inoue T K, Ikezaki K, Sasazuki T et al.
Linkage analysis of moyamoya disease on chromosome 6.
J Child Neurol.
2000;
15 (3)
179-182
-
26
Kraemer M, Berlit P.
Primary central nervous system vasculitis and moyamoya disease: similarities and differences.
J Neurol.
2009;
257
816-819
-
27
Horn P, Lanczik O, Vajkoczy P et al.
Hemodynamic reserve and high-intensity transient signals in moyamoya disease.
Cerebrovasc Dis.
2005;
19 (3)
141-146
-
28
Tagawa T, Naritomi H, Mimaki T et al.
Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease.
Stroke.
1987;
18 (5)
906-910
-
29
Tagawa R, Naritomi H, Mimaki T et al.
Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease.
Stroke.
1987;
18
906-910
-
30
Kuroda S, Houkin K.
Moyamoya disease: current concepts and future perspectives.
Lancet Neurol.
2008;
7
1056-1066
-
31
Ishikawa T, Kuroda S, Nakayama N et al.
Prevalence of asymptomatic microbleeds in patients with moyamoya disease.
Neurol Med Chir.
2005;
45
495-500
; discussion 500
-
32
Papanagiotou P, Grunwald I Q, Politi M et al.
Moyamoya disease.
Radiologe.
2005;
45
466-470
-
33
Lee M, Zaharchuk G, Guzman R et al.
Quantitative hemodynamic studies in moyamoya disease: a review.
Neurosurg Focus.
2009;
26
E5
-
34
Perren F, Horn P, Vajkoczy P et al.
Power Doppler imaging in detection of surgically induced indirect neoangiogenesis in adult moyamoya disease.
J Neurosurg.
2005;
103
869-872
-
35
Umemura A, Yamada K, Masago A et al.
Hemodynamic flow patterns evaluated by transcranial color-coded duplex sonography after STA-MCA bypass for internal carotid artery occlusion.
Cerebrovasc Dis.
2002;
14
143-147
-
36
Iguchi Y, Kimura K, Tateishi Y et al.
Microembolic signals are associated with progression of arterial lesion in moyamoya disease: a case report.
J Neurol Sci.
2007;
260
253-255
-
37
Woitzik J, Horn P, Vajkoczy P et al.
Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography.
J Neurosurg.
2005;
102
692-698
-
38
Huang A P, Liu H M, Lai D M et al.
Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
Cerebrovasc Dis.
2009;
28
247-257
-
39
Kornblihtt L I, Cocorullo S, Miranda C et al.
Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement.
Stroke.
2005;
36
E71-E73
-
40
Rodriguez G J, Kirmani J F, Ezzeddine M A et al.
Primary percutaneous transluminal angioplasty for early moyamoya disease.
J Neuroimaging.
2007;
17
48-53
-
41
Arita K, Kurisu K, Ohba S et al.
Endovascular treatment of basilar tip aneurysms associated with moyamoya disease.
Neuroradiology.
2003;
45
441-444
-
42
Touho H.
Patch angioplasty to repair the arteriotomy defect in the wall of the middle cerebral artery after failure of superficial temporal artery-middle cerebral artery anastomosis in moyamoya disease – case report.
Neurol Med Chir.
2002;
42
435-438
-
43
Tezcan H, Yavuz S, Fak A S et al.
Coronary stent implantation in Behcet’s disease.
Clin Exp Rheumatol.
2002;
20
704-706
-
44
Both M, Jahnke T, Reinhold-Keller E et al.
Percutaneous management of occlusive arterial disease associated with vasculitis: a single center experience.
Cardiovasc Intervent Radiol.
2003;
26
19-26
-
45
Liang P, Tan-Ong M, Hoffman G S.
Takayasu’s arteritis: vascular interventions and outcomes.
J Rheumatol.
2004;
31
102-106
-
46
Andrade J, Al A li A, Saw J et al.
Acute stent thrombosis in a patient with giant cell arteritis.
Can J Cardiol.
2008;
24
E25-E26
-
47
Kobayashi E, Saeki N, Oishi H et al.
Long-term natural history of hemorrhagic moyamoya disease in 42 patients.
J Neurosurg.
2000;
93
976-980
-
48
Kuroda S, Hashimoto N, Yoshimoto T et al.
Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan.
Stroke.
2007;
38
1430-1435
Dr. med. Markus Krämer
Klinik für Neurologie und klinische Neurophysiologie
Alfried-Krupp-Krankenhaus
Alfried-Krupp-Straße 21
45117 Essen
eMail: Markus.kraemer@krupp-krankenhaus.de
